|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MEMBRANE TRANSPORTERS, ION CHANNELS, AND PUMPS
1Department of Medicine, Queen Mary Hospital, and 2Institute of Cardiovascular Science and Medicine, University of Hong Kong, Hong Kong; 3Stem Cell Program and 4Department of Cell Biology and Human Anatomy, University of California, Davis; and 5Institute of Pediatric Regenerative Medicine, Shriners Hospital for Children of North America, Sacramento, California
Submitted 1 August 2007 ; accepted in final form 23 October 2007
| ABSTRACT |
|---|
|
|
|---|
6 mV) and decelerated gating kinetics (by up to 3-fold). Based on these results, we conclude that pore residues 339–345 are important determinants of the structure-function properties of HCN channels and that the side chain of H344 is externally accessible. hyperpolarization-activated cyclic nucleotide; cysteine mutagenesis; sulfhydryl modification
1:100 of K+ channels) and are activated upon hyperpolarization rather than depolarization of classical voltage-gated K+ (Kv) channels. Despite these differences in permeation and gating, however, HCN and Kv channels have highly homologous primary amino acid sequences. Structurally, both are tetramers of monomeric subunits consisting of six membrane-spanning segments (S1–S6), each including a positively charged voltage-sensing S4 segment and a P loop between S5 and S6 that forms part of the ion-conducting pore (Fig. 1). The pore region can be further subdivided into three regions: the S5-P and P-S6 linkers form the extrapore and the descending and ascending limbs of the P loop, where the permeation determinant GYG motif is located, constitute the deeper region of the extracellular pore (Fig. 1). The cytoplasmic side of the pore is believed to consist of S6 segments (22).
|
| MATERIALS AND METHODS |
|---|
|
|
|---|
Oocyte preparation and heterologous expression. Stage IV–VI oocytes were surgically removed from female Xenopus laevis anesthetized by immersion in 0.3% 3-aminobenzoic acid ethyl ester, followed by digestion with 1 mg/ml collagenase (type IA) in OR2 solution containing 88 mM NaCl, 2 mM KCl, 1 mM MgCl2, and 5 mM HEPES (titrated to pH 7.6 with NaOH) for 30–60 min. Isolated oocytes were stored in ND96 solution containing 96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, and 5 mM HEPES (titrated to pH 7.6 with NaOH) supplemented with 50 µg/ml gentamycin, 5 mM pyruvate, and 0.5 mM theophylline. Within 5 h after isolation, each oocyte was injected with 50 ng cRNA (1 ng/1 nl). Oocytes were studied 24–48 h after cRNA injection. The protocol was approved by the University ethical committee with protocol number 05-12026.
Preparation of oocyte membrane fractions and Western blot analysis. Injected and control (uninjected) oocytes were homogenized in ice-cold PBS containing an EDTA-free protease inhibitor cocktail (1 tablet/10 ml, Roche Applied Science) and centrifuged for 10 min at 1,000 g to remove pigment and nuclear and mitochondrial materials. The supernatant was fractioned into cytosolic and membrane fractions by ultracentrifugation at 120,000 g for 1 h at 4°C. The membrane fraction was resuspended in 1x LDS sample buffer and electrophoresed on a 10% polyacrylamide-SDS gel. Membrane proteins were then transferred onto a nitrocellulose membrane, followed by blockade with 5% nonfat dried milk for 1 h. Blocked membranes were washed in Tris-buffered saline-Tween (TBST) and incubated with a purified rabbit polycolonal anti-HCN1 antibody (Alomone Labs, Jerusalem, Israel) at a 1:200 dilution for 4°C overnight, followed by a wash in TBST and an incubation with horseradish peroxidase-conjugated donkey anti-rabbit immunoglobulin (Chemicon, Temecula, CA) diluted to 1:10,000 in 5% nonfat dried milk for 1 h at room temperature. Membranes were washed again three times in TBST, and bound secondary antibodies were detected with an ECL detection kit (Chemicon) by autoradiography.
Electrophysiology.
Two-electrode voltage-clamp recordings were performed at room temperature using a Warner C-725B amplifier. The measuring electrodes (TW120-6, World Precision Instruments, Sarasota, FL), whose tips were plugged with 1% agarose dissolved in 3 M KCl solution, were pulled using a Narishige PP-83 vertical puller. When backfilled with 3 M KCl solution, the typical electrode resistances were
2–5 M
. The recording bath solution contained 96 mM KCl, 2 mM NaCl, 2 mM MgCl2, and 10 mM HEPES (titrated to pH 7.5 with NaOH).
For the steady-state current-voltage (I-V) protocol, whole cell currents were measured at the end of a 3-s pulse from –140 to 0 mV from a holding potential of –30 mV against the test potentials. The voltage dependence of HCN channel activation was assessed by plotting tail currents measured immediately after a pulse to –140 mV as a function of the preceding 3-s test pulse normalized to the tail current at –140 mV. Data were fitted to the Boltzman function using the Marquardt-Levenberg algorithm in a nonlinear least-squares procedure:
![]() |
) (where R is the gas constant, T is temperature, z is valence, and F is Faraday's constant) (5, 30). For current kinetics, activation (
act) and deactivation (
deact) time constants were estimated by fitting macroscopic currents with a monoexponential function.
To test for Cd2+ sensitivity, each oocyte expressing a HCN1-R pore cysteine construct was first stimulated by a 2-s voltage pulse from a holding voltage of 0 mV to a test voltage of –140 mV. The steady-state current at –140 mV was used as the initial current magnitude against which currents after CdCl2 exposure were compared. Immediately after the initial test pulse, cells were exposed to varying concentrations of CdCl2 (3 µM–1 mM). Voltage pulses (from 0 to –140 mV, 2-s duration) were then applied every minute until steady-state current blockade was reached. The fractional block by CdCl2 was plotted against [CdCl2] to generate a binding isotherm. Data were fitted to the Hill equation using the Marquardt-Levenberg algorithm in a nonlinear least-squares procedure:
![]() |
MTS ethylammonium (MTSEA; Toronto Research Chemicals, Toronto, ON, Canada) powder was dissolved in deionized water at 0.2 M shortly before experiments were performed. The stock solution was stored on ice and used with 1 h. The MTS solution was applied extracellularly after all control data were obtained. The MTS stock solution was diluted with the bath solution to 2 mM and applied to the oocyte immediately. The time course of MTS modification was fit with the following single-exponential equation:
![]() |
MTS is the time constant for MTS modification, and S is the steady-state plateau. All data reported are means ± SE. Statistical significance was determined using an unpaired Student's t-test.
| RESULTS |
|---|
|
|
|---|
|
|
|
|
5 min with a time constant of 300 ± 30 s. When the stimulation frequency was slowed to 0.03 Hz, it took
10 min to achieve the steady-state block with a time constant of 600 ± 38 s, although the reduction of IMTSEA/Icontrol,–140 mV (43.7 ± 6.5%, n = 3, P > 0.05) was identical (Fig. 5B).
|
|
76 kDa, as expected for the size for the HCN1 monomer both under control (oxidizing) conditions and after DTT incubation. Without DTT treatment, additional bands at
150 kDa that appeared to be cross-linked dimers were seen for the cysteine-substituted pore constructs F339C, K340C, A341C, M342C, H344C, and M345C. However, these dimers were not seen in S343C channels. Of note, K340C channels expressed only dimers, whereas F339C, A341C, M342C, H344C, and M345C channels displayed both monomers and dimers under control conditions. Interestingly, all dimers disappeared after DTT treatment and only monomers similar to those observed with WT and HCN1-R channels were seen. All constructs displayed bands with intensity comparable with those of WT and HCN1-R channels (with the same cRNA amounts injected), suggesting that protein synthesis and translational efficiency were similar for all of the channels studied. The same pattern was observed in three other experiments independently performed with different batches of Xenopus oocytes.
|
| DISCUSSION |
|---|
|
|
|---|
Residue 344 is exposed to the aqueous phase and externally accessible by Cd2+ and MTSEA. Previously, we reported that the endogenous cysteine C318 in the S5-P linker, located in the outermost rim of the external pore mouth, can be covalently modified by MTS reagents; MTS modification negatively shifted steady-state activation and decelerates gating kinetics (30). Based on these results, we propose that the pore and gate of mammalian HCN channels are allosterically coupled in a manner analogous to the C type and slow inactivation of depolarization-activated K+ and Na+ channels (2, 30). A similar mechanism of pore motion has also been proposed for CNG channels (3, 4, 7, 15, 17, 19, 23). Like C318, C344 can be modified by external MTSEA. MTSEA modification reduced the macroscopic current of both C318 (i.e., WT) and H344C channels. Despite these similarities, WT and H344C channels differ in several aspects from which new insights into the pore can be obtained. For instance, MTSEA reduced the current through WT channels largely by substantially shifting their steady-state activation by
50 mV (30). Steric hindrance of the pore by the MTS moiety accounted for only
35% of the inhibition. Furthermore, WT and C318S channels displayed the same sensitivity to Cd2+ blockade. In contrast, MTSEA modification only modestly shifted activation gating of H344C channels (by
5 mV), indicating that current inhibition is primarily due to pore obstruction by the MTS moiety covalently attached to residue 344. Also, H344C channels were sensitive to Cd2+. Taken together, these observations are consistent with the notion that residue 344 is located in the relatively narrow portion of the external permeation pathway. Interestingly, our MTSEA experiment further suggests that the accessibility of residue 344 is state dependent, also unlike C318 (30). The effects observed with H344C channels are site specific because the same was not seen with F339C channels. Mapping the entire HCN P segment, including the ascending portion of the P loop and the P-S6 linker, will provide a more comprehensive footprint of the pore.
Our results also underscore the importance of residues K340, A341, M342, S343, and M345 structural and functional determinants. When substituted, channel functions are abolished, although the proteins are expressed not differently from WT and HCN1-R channels. Interestingly, F339C, K340C, A341C, M342C, and M345C channels are able to cross-link among themselves to form dimers, which can be reduced to monomers. Of note, the HCN1-R channel contains one remaining endogenous cysteine (i.e., C303) that could also cross-link to disrupt channel functions. However, such an internal disulfide bridge would not lead to the formation of dimers; the possibility of cross-linking individual cysteines from distinct monomers is less likely assuming that the pore structure is analogous to those of K channels that have been characterized (e.g., KcsA) (13). These results shed structural insights into the rather poorly defined HCN pore. For instance, free sulhydryls can cross-link only when they come close into the proximity of each other (with the
-carbons at particular angles). Furthermore, the formation of disulfide bridge is a dynamic process; completion occurs when both the intersulfhydryl distance and orientation are optimal (9). Since a mixture of dimers and monomers was observed only with F339C, A341C, M342C, and M345C channels but only dimers for K340C channels under control conditions, our results raise the possibility that the intercysteine distance of K340C channels is probably the closest. The lack of measurable functional currents from K340C, A341C, M342C, S343C, and M345C channels, however, did not enable us to assess the accessibility of the corresponding substituted cysteines.
F339C channels are unique in that their loss of function can be rescued by DTT treatment, but the restored currents are sensitive to neither Cd2+ nor MTSEA. While we cannot exclude the possibility that Cd2+ binding or MTSEA modification of C339 does not lead to functional changes due to its distance from the permeation pathway, residue C339 is most likely not exposed given its location between the highly modifiable outermost C318 and C344 that is deeper into the pore. Nevertheless, C339 residues from adjacent monomers may cross-link to form dimers during protein synthesis or trafficking. Further experiments will be needed to dissect the underlying mechanisms.
Based on our results, we conclude that residue 344 is exposed to the aqueous phase. Residues 339–345 from the S5-P linker are important determinants of the structure-function properties of HCN channels.
| GRANTS |
|---|
|
|
|---|
| FOOTNOTES |
|---|
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
| REFERENCES |
|---|
|
|
|---|
2. Azene EM, Xue T, Li RA. Molecular basis of the effect of potassium on heterologously expressed pacemaker (HCN) channels. J Physiol 547: 349–356, 2003.
3. Becchetti A, Gamel K. The properties of cysteine mutants in the pore region of cyclic-nucleotide-gated channels. Pflügers Arch 438: 587–596, 1999.[CrossRef][Web of Science][Medline]
4. Becchetti A, Gamel K, Torre V. Cyclic nucleotide-gated channels. Pore topology studied through the accessibility of reporter cysteines. J Gen Physiol 114: 377–392, 1999.
5. Bell DC, Yao H, Saenger RC, Riley JH, Siegelbaum SA. Changes in local S4 environment provide a voltage-sensing mechanism for mammalian hyperpolarization-activated HCN channels. J Gen Physiol 123: 5–19, 2004.[CrossRef][Web of Science][Medline]
6. Brown HF, Giles W, Noble SJ. Membrane currents underlying activity in frog sinus venosus. J Physiol 271: 783–816, 1977.
7. Bucossi G, Nizzari M, Torre V. Single-channel properties of ionic channels gated by cyclic nucleotides. Biophys J 72: 1165–1181, 1997.[Web of Science][Medline]
8. Chen S, Wang J, Siegelbaum SA. Properties of hyperpolarization-activated pacemaker current defined by coassembly of HCN1 and HCN2 subunits and basal modulation by cyclic nucleotide. J Gen Physiol 117: 491–504, 2001.
9. Creighton TE. Protein Folding. New York: Freeman, 1992.
10. DiFrancesco D. A new interpretation of the pace-maker current in calf Purkinje fibres. J Physiol 314: 359–376, 1981.
11. DiFrancesco D. Pacemaker mechanisms in cardiac tissue. Annu Rev Physiol 55: 455–472, 1993.[CrossRef][Web of Science][Medline]
12. DiFrancesco D. A study of the ionic nature of the pace-maker current in calf Purkinje fibres. J Physiol 314: 377–393, 1981.
13. Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R. The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science 280: 69–77, 1998.
14. Er F, Larbig R, Ludwig A, Biel M, Hofmann F, Beuckelmann DJ, Hoppe UC. Dominant-negative suppression of HCN channels markedly reduces the native pacemaker current If and undermines spontaneous beating of neonatal cardiomyocytes. Circulation 107: 485–489, 2003.
15. Flynn GE, Zagotta WN. Conformational changes in S6 coupled to the opening of cyclic nucleotide-gated channels. Neuron 30: 689–698, 2001.[CrossRef][Web of Science][Medline]
16. Gauss R, Seifert R, Kaupp UB. Molecular identification of a hyperpolarization-activated channel in sea urchin sperm. Nature 393: 583–587, 1998.[CrossRef][Medline]
17. Gavazzo P, Picco C, Eismann E, Kaupp UB, Menini A. A point mutation in the pore region alters gating, Ca2+ blockage, and permeation of olfactory cyclic nucleotide-gated channels. J Gen Physiol 116: 311–326, 2000.
18. Hille B. Ionic Channels of Excitable Membranes. Sunderland, MA: Sinauer, 2002.
19. Kaupp UB, Seifert R. Cyclic nucleotide-gated ion channels. Physiol Rev 82: 769–824, 2002.
20. Ludwig A, Zong X, Jeglitsch M, Hofmann F, Biel M. A family of hyperpolarization-activated mammalian cation channels. Nature 393: 587–591, 1998.[CrossRef][Medline]
21. Pape HC. Queer current and pacemaker: the hyperpolarization-activated cation current in neurons. Annu Rev Physiol 58: 299–327, 1996.[CrossRef][Web of Science][Medline]
22. Prole DL, Yellen G. Reversal of HCN channel voltage dependence via bridging of the S4–S5 linker and post-S6. J Gen Physiol 128: 273–282, 2006.
23. Root MJ, MacKinnon R. Identification of an external divalent cation-binding site in the pore of a cGMP-activated channel. Neuron 11: 459–466, 1993.[CrossRef][Web of Science][Medline]
24. Santoro B, Chen S, Luthi A, Pavlidis P, Shumyatsky GP, Tibbs GR, Siegelbaum SA. Molecular and functional heterogeneity of hyperpolarization-activated pacemaker channels in the mouse CNS. J Neurosci 20: 5264–5275, 2000.
25. Santoro B, Liu DT, Yao H, Bartsch D, Kandel ER, Siegelbaum SA, Tibbs GR. Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93: 717–729, 1998.[CrossRef][Web of Science][Medline]
26. Santoro B, Tibbs GR. The HCN gene family: molecular basis of the hyperpolarization-activated pacemaker channels. Ann NY Acad Sci 868: 741–764, 1999.[CrossRef][Web of Science][Medline]
27. Siu CW, Lieu DK, Li RA. HCN-encoded pacemaker channels: from physiology and biophysics to bioengineering. J Membr Biol 214: 115–122, 2006.[CrossRef][Web of Science][Medline]
28. Ulens C, Tytgat J. Functional heteromerization of HCN1 and HCN2 pacemaker channels. J Biol Chem 276: 6069–6072, 2001.
29. Wahl-Schott C, Baumann L, Zong X, Biel M. An arginine residue in the pore region is a key determinant of chloride dependence in cardiac pacemaker channels. J Biol Chem 280: 13694–13700, 2005.
30. Xue T, Li RA. An external determinant in the S5-P linker of the pacemaker (HCN) channel identified by sulfhydryl modification. J Biol Chem 277: 46233–46242, 2002.
31. Xue T, Marban E, Li RA. Dominant-negative suppression of HCN1- and HCN2-encoded pacemaker currents by an engineered HCN1 construct: insights into structure-function relationships and multimerization. Circ Res 90: 1267–1273, 2002.
32. Yanagihara K, Irisawa H. Potassium current during the pacemaker depolarization in rabbit sinoatrial node cell. Pflügers Arch 388: 255–260, 1980.[CrossRef][Web of Science][Medline]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |